Volume Reduction: Which Dose is Sufficient to Retain Resistance Training Adaptations in Older Women?
Melissa AntunesWitalo KassianoAnaliza M SilvaBrad J SchoenfeldAlex S RibeiroBruna Daniella de Vasconcelos CostaPaolo Marcello da CunhaPaulo Sugihara JúniorLetícia T CyrinoDenilson C TeixeiraLuís B SardinhaEdilson S CyrinoPublished in: International journal of sports medicine (2021)
We compared the effects of different resistance training (RT) volume reduction strategies on muscular strength and lean soft-tissue (LST) in older women. Fifty-seven physically independent women (>60 years) performed a 20-week pre-conditioning phase of a standardized whole-body RT program (eight exercises, three sets, 8-12 repetitions, three sessions a week), and were then randomly assigned to one of the following conditions: reduced volume for a single set (RV1, n=20) or two sets (RV2, n=19), or maintained volume of three sets (MV, n=18) for 8 weeks (specific training phase). Muscular strength in the chest press, leg extension, and preacher curl exercises was determined by one-repetition maximum tests. A dual-energy X-ray absorptiometry device was used to estimate LST. An increase in muscular strength (16.3-32.1%) and LST (3.2-7.9%) was observed after the pre-conditioning phase. There was an increase in chest press for all groups (9.4-16.7%) after the specific training phase. In contrast, only MV increased significantly in the leg extension (4.4%). No between-group differences were revealed for LST in the specific training phase. Our results suggest that reduced RT volume from three to one set per exercise for 8 weeks seems sufficient to retain neuromuscular adaptations in older women.
Keyphrases
- resistance training
- high intensity
- body composition
- dual energy
- computed tomography
- mycobacterium tuberculosis
- bone mineral density
- randomized controlled trial
- clinical trial
- high resolution
- magnetic resonance
- virtual reality
- metabolic syndrome
- type diabetes
- physical activity
- polycystic ovary syndrome
- study protocol
- insulin resistance